News

Aon lifts capacity to $2.5b as AI drives complexity

Aon lifts capacity to $2.5b as AI drives complexity

The facility spans construction, all risks, delay in start-up and operational damage coverage.

Taiwan FSC rewrites life insurer forex reporting rules

Unamortised balance stays on the balance sheet, hitting income only at sale.

Zurich Resilience Solutions names Robin Matthias as global head

Matthias succeeds Dirk De Nil, who is retiring after a 35-year career.

Chaucer appoints Les Loh as Singapore CEO

Loh joins from Guy Carpenter, where he led Southeast Asia and Korea.

Swiss Re overhauls flood model with Fathom data

Work follows Swiss Re’s December 2023 acquisition of Fathom.

Allianz Trade launches Social2Social to cover political risk

Eligibility requires a sustainability team review under Allianz Trade social criteria.

Bupa appoints Antonio Cantó as Hong Kong managing director

He previously served as CEO of Bupa Chile, after running Sanitas Seguros for 12 years.

Insured losses top $108b as disasters strain insurers

Economic damage reached about $224b, with most impacts in highly protected regions.

India’s life insurance industry surges 40% YoY in December 2025

This was a rebound from the contraction seen in August 2025.

bolttech partners with electronics giant, unveils device protection plan

The programme starts in Hong Kong, initially limited to cameras and lenses.

Run-off specialists reshape insurer capital deals, AM Best says

Report says some firms reprice risks, add reserve buffers, and cap exposure.

India life insurers face margin squeeze as sales climb

Policy count rose 15% in Q3 FY26; An insurer logged 27% APE growth in December.

Japanese firms absorb rising insurable risk costs, Aon says

Aon finds 74.7% have risk units, yet 47.6% still report exchange-rate-linked losses.

Vietnam tightens social insurance enforcement against evasion

Mandatory enrollment expands: local data sharing to flag non-compliance.

Insurance consolidation forces brokers to upgrade technology

Deal activity climbed through 2022, then stayed steady afterward—setting a tougher baseline.

China adds 114 drugs to national medical insurance list

The country’s commercial insurance innovative drug list now has 19 medications.